Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1139 Results

Title
Intervention Indication Therapeutic Area Year Actions
Fedratinib for Myelofibrosis Fedratinib (SAR302503) Myelofibrosis Haematological Cancer and Lymphomas , Haematology 2018 View  |  Download
Fedovapagon for nocturia in men with benign prostatic hyperplasia Fedovapagon (VA-106483) Nocturia Men's Health , Urology 2018 View  |  Download
Favezelimab-Pembrolizumab for treating relapsed or refractory classical Hodgkin Lymphoma after 2 or more therapies Favezelimab-pembrolizumab Hodgkin lymphoma Haematological Cancer and Lymphomas 2023 View  |  Download
Favezelimab-pembrolizumab for treating metastatic PD-L1 positive colorectal cancer Favezelimab-pembrolizumab Colorectal cancer Gastrointestinal Cancer , Oncology 2023 View  |  Download
Faricimab for neovascular age-related macular degeneration Faricimab (RO6867461; RG 7716) Age-related macular degeneration (AMD) Ophthalmology 2020 View  |  Download
Faricimab for macular oedema secondary to retinal vein occlusion Faricimab (RO6867461; RG 7716) Retinal Vein Occlusion Ophthalmology 2022 View  |  Download
Faricimab for diabetic macular oedema Faricimab (RO6867461; RG 7716) Diabetic macular oedema Endocrine Nutritional and Metabolic Disorders , Ophthalmology 2020 View  |  Download
Evolocumab for preventing major cardiovascular events in adults with a high risk of cardiovascular events Evolocumab Cardiovascular events Cardiovascular System 2023 View  |  Download
Evobrutinib for treating relapsing multiple sclerosis Evobrutinib Multiple sclerosis (MS) Neurology 2023 View  |  Download
Evinacumab for treating homozygous familial hypercholesterolemia in children Evinacumab (REGN1500) Homozygous familial hypercholesterolemia Endocrine Nutritional and Metabolic Disorders , Genetic Disorders 2022 View  |  Download
1 2 72 73 74 75 76 113 114
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications